Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C12H10ClN3O |
| Molecular Weight | 247.68 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N1C=CN=C1)C2=NOC3=C2C=C(Cl)C=C3
InChI
InChIKey=QMKRARTVXMQOBW-UHFFFAOYSA-N
InChI=1S/C12H10ClN3O/c1-8(16-5-4-14-7-16)12-10-6-9(13)2-3-11(10)17-15-12/h2-8H,1H3
| Molecular Formula | C12H10ClN3O |
| Molecular Weight | 247.68 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Zoniclezole was proven to have anticonvulsant profile. It is representative of a novel class of water-soluble agents being developed for the treatment of epilepsy. Zoniclezole has been shown to be a potential antagonist of electroshock-induced seizures in animals, and to some degree, pentylenetetrazol-induced seizures. In preclinical studies the compound had prolonged efficacy at relatively low doses. Zoniclezole is glutamate receptor antagonist.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:21:01 GMT 2025
by
admin
on
Mon Mar 31 18:21:01 GMT 2025
|
| Record UNII |
H1C5F0K79E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20869671
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
C078649
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
100000078799
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
H1C5F0K79E
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
60745
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111150
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
121929-20-2
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
SUB00186MIG
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
6912
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY | |||
|
C82235
Created by
admin on Mon Mar 31 18:21:01 GMT 2025 , Edited by admin on Mon Mar 31 18:21:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
